 |
|
|
| |
NGM282 DEMONSTRATES ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES THAT ARE INDEPENDENT OF STEATOSIS REDUCTION IN A FARNESOIDX RECEPTOR (FXR)-DEFICIENT, DIET-INDUCED ANIMAL MODEL OF NON-ALCOHOLIC STEATOHEPATITIS(NASH)
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Lei Ling, Mei Zhou, Marc Learned, Stephen Rossi, Alex DePaoli, Hui Tian
NGM Biopharmaceuticals, Inc., South San Francisco, CA 94080, USA
|
| |
|
|
|
|
|
